| Literature DB >> 16787750 |
Thorsten Gerstner1, Deike Buesing, Elke Longin, Claudia Bendl, Dieter Wenzel, Brigitte Scheid, Gisela Goetze, Alfons Macke, Gerhard Lippert, Wolfgang Klostermann, Geert Mayer, Regine Augspach-Hofmann, Sabine Fitzek, Carl-Albrecht Haensch, Markus Reuland, Stephan A Koenig.
Abstract
Valproic acid (VPA) is a broad-spectrum antiepileptic drug and is usually well-tolerated. Rare serious complications may occur in some patients, including haemorrhagic pancreatitis, bone marrow suppression, VPA-induced hepatotoxicity and VPA-induced encephalopathy. The typical signs of VPA-induced encephalopathy are impaired consciousness, sometimes marked EEG background slowing, increased seizure frequency, with or without hyperammonemia. There is still no proof of causative effect of VPA in patients with encephalopathy, but only of an association with an assumed causal relation. We report 19 patients with VPA-associated encephalopathy in Germany from the years 1994 to 2003, none of whom had been published previously.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16787750 DOI: 10.1016/j.seizure.2006.05.007
Source DB: PubMed Journal: Seizure ISSN: 1059-1311 Impact factor: 3.184